On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment

  • SOBRsafe recently signed hardware/software agreements with Lighthouse Recovery Resources and Mountain House Recovery, both operating in the U.S. behavioral health segment
  • The two new agreements bring the number of new accounts secured in 2024 to 20, compared to three accounts booked in all of 2023
  • The company is targeting the behavioral health and justice segments, which mandate the use of alcohol testing
  • According to SOBRsafe’s CEO, while businesses and services in the behavioral health and justice segments already use different alcohol testing technologies, they are hungry for evolved solutions
  • SOBRsafe offers SOBRcheck(TM) and SOBRsure, designed to instantaneously detect and report the presence of alcohol as emitted through the skin

SOBRsafe (NASDAQ: SOBR) provides next-generation transdermal alcohol detection technology, which simplifies the alcohol detection process. The proprietary technology combines an NIAAA-awarded gas sensor with proprietary algorithms to capture alcohol vapor emitted through pores, detecting alcohol 2-3x faster than other transdermal solutions with accuracy that approaches 99% at heavy consumption levels (https://ibn.fm/371c7). The technology can be found in the company’s suite of products: SOBRcheck(TM), a high-volume passive alcohol screening solution for stationary use, and SOBRsure(TM), a wearable wristband that provides continuous, mobile alcohol monitoring.

Guided by its stated vision to become the global standard for alcohol screening and monitoring, SOBRsafe aims to offer its products primarily to the behavioral health and justice segments, which promise high adoption rates. According to the company, the decision to focus on these markets hinges on the fact that businesses and service providers in these sectors already use different alcohol testing technologies, with testing mandated. “It’s not a want; it’s a need. These sectors already use alcohol detection products as a matter of standard procedure, but are hungry for evolved monitoring and screening solutions,” said SOBRsafe Chairman and CEO Dave Gandini in a recent video update (https://ibn.fm/L9isT).

The need for better alcohol monitoring solutions has pushed businesses and service providers toward SOBRsafe, with the company signing multiple agreements with an ever-growing number of partners keen on adopting its next-generation solutions. So far, in 2024, the company has secured 20 new accounts, compared to three accounts booked in all of 2023. Most recently, SOBRsafe announced the signing of hardware/software agreements with Lighthouse Recovery Resources and Mountain House Recovery, both operating in the behavioral health market (https://ibn.fm/jgdfJ).

Based in Carbondale, Colorado, Lighthouse provides individuals and families with the resources and support they need to achieve lasting recovery. Its services include interventions, sober companions, and care management. Lighthouse has purchased an initial 10 SOBRsure wristbands to monitor high-risk patients round the clock and actively intercept alcohol use. It believes the wristband empowers accelerated intervention compared to breathalyzers and other traditional testing methods.

For its part, Mountain House Recovery, a Flagstaff, Arizona-based provider of a post-treatment launching pad where men in early recovery can forge lasting friendships and embark on a transformative journey to sobriety, is integrating SOBRsafe’s SOBRcheck in its residential facility to replace breathalyzers. Mountain House believes SOBRcheck’s transdermal alcohol detection mechanism provides a more humane and less stigmatizing testing approach. In addition, the service provider also views SOBRcheck as a cost-reduction measure, as it enables 24/7 unmanned alcohol testing at check-in and check-out, eliminating an administrative expense.

In the video update, Dave Gandini captured the exact concerns of its new partners, saying, “Traditional detection methods using breath, blood or urine tests have a host of drawbacks, including being invasive, inefficient, and unhygienic – and often degrading. Plus, breathalyzer-type devices have a limited life and are often inaccurate and subject to breaking down and their output is typically analog and requires a staff member to write results down and hopefully log them accurately into a patient’s records.”

In contrast, SOBRcheck and SOBRsure accurately detect the presence of alcohol as emitted through the skin and do not require the user to provide a breath, blood, or urine sample. Each device is independently connected to SOBRsafe’s powerful backend data platform, which facilitates instantaneous reporting, real-time data management, and predictive analytics. Together, SOBRsafe’s next-generation solutions help create a culture of prevention and support.

For more information, visit the company’s website at www.SOBRsafe.com.

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

From Our Blog

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

July 23, 2024

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have […]

Rotate your device 90° to view site.